DMRTC2

gene
On this page

Also known as DMRT7

Summary

DMRTC2 (DMRT like family C2, HGNC:13911) is a protein-coding gene on chromosome 19q13.2, encoding Doublesex- and mab-3-related transcription factor C2 (Q8IXT2). May be involved in sexual development.

Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in cell differentiation; regulation of transcription by RNA polymerase II; and sex differentiation. Predicted to act upstream of or within heterochromatin organization; male meiosis I; and spermatid nucleus elongation. Predicted to be located in chromatin. Predicted to be active in nucleus.

Source: NCBI Gene 63946 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 53 total
  • MANE Select transcript: NM_001040283

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13911
Approved symbolDMRTC2
NameDMRT like family C2
Location19q13.2
Locus typegene with protein product
StatusApproved
AliasesDMRT7
Ensembl geneENSG00000142025
Ensembl biotypeprotein_coding
OMIM614806
Entrez63946

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 5 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000269945, ENST00000596258, ENST00000596660, ENST00000596827, ENST00000599022, ENST00000600017, ENST00000601660, ENST00000602098

RefSeq mRNA: 1 — MANE Select: NM_001040283 NM_001040283

CCDS: CCDS33034

Canonical transcript exons

ENST00000269945 — 9 exons

ExonStartEnd
ENSE000009518844185031241850372
ENSE000009518854185052641850700
ENSE000011643544185158441852333
ENSE000013093234184879541848975
ENSE000030104934184504241845101
ENSE000035368884184773641847881
ENSE000035379704184845241848528
ENSE000035460944184742541847652
ENSE000036139754184913041849256

Expression profiles

Bgee: expression breadth broad, 53 present calls, max score 94.35.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1005 / max 114.5756, expressed in 3 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1760710.06803
1760690.01893
1760700.01363

Top tissues by expression

212 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right testisUBERON:000453494.35gold quality
left testisUBERON:000453393.50gold quality
testisUBERON:000047391.33gold quality
spermCL:000001987.08gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.38gold quality
secondary oocyteCL:000065584.42gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.60gold quality
oocyteCL:000002373.86gold quality
adult organismUBERON:000702372.47gold quality
buccal mucosa cellCL:000233659.25gold quality
tibialis anteriorUBERON:000138555.01silver quality
cardiac muscle of right atriumUBERON:000337954.34gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
kidney epitheliumUBERON:000481953.93gold quality
epithelial cell of pancreasCL:000008353.84gold quality
upper arm skinUBERON:000426353.52gold quality
bloodUBERON:000017853.45gold quality
pancreatic ductal cellCL:000207953.33silver quality
deltoidUBERON:000147651.16gold quality
myocardiumUBERON:000234950.25gold quality
quadriceps femorisUBERON:000137748.89gold quality
vastus lateralisUBERON:000137948.00gold quality
ileal mucosaUBERON:000033147.44silver quality
colonic epitheliumUBERON:000039747.03gold quality
nasal cavity epitheliumUBERON:000538447.03gold quality
upper leg skinUBERON:000426243.71silver quality
bone marrowUBERON:000237143.69gold quality
layer of synovial tissueUBERON:000761643.55gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
muscle tissueUBERON:000238541.85gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.78

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA1479.1DMRTC2DMRT factors
MA1479.2DMRTC2DMRT factors

JASPAR matrix evidence (PMIDs): PMID:25215497

miRNA regulators (miRDB)

26 targeting DMRTC2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-335-3P99.9373.364958
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-153-5P99.8973.866317
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-6857-5P99.8765.32985
HSA-MIR-6752-3P99.7266.711587
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-4743-3P99.6268.122095
HSA-MIR-569399.2466.671106
HSA-MIR-4520-2-3P99.1469.281009
HSA-MIR-4999-3P99.1165.55424
HSA-MIR-3117-5P99.0467.93618
HSA-MIR-500A-5P98.7669.131241
HSA-MIR-6804-3P98.7264.82852
HSA-MIR-126198.6268.10896
HSA-MIR-5581-3P98.5570.311161
HSA-MIR-445098.2668.35725
HSA-MIR-6773-3P98.1765.511213
HSA-MIR-7850-5P98.1267.281111
HSA-MIR-6841-5P97.1967.29409
HSA-MIR-215-3P97.0268.011209
HSA-MIR-71196.6065.75528

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusDmrtc2ENSMUSG00000011349
rattus_norvegicusDmrtc2ENSRNOG00000020109
caenorhabditis_elegansWBGENE00019521
caenorhabditis_elegansWBGENE00022060

Paralogs (8): DMRT3 (ENSG00000064218), DMRT1 (ENSG00000137090), DMRTA2 (ENSG00000142700), DMRTB1 (ENSG00000143006), DMRT2 (ENSG00000173253), DMRTA1 (ENSG00000176399), DMRTC1B (ENSG00000184911), DMRTC1 (ENSG00000269502)

Protein

Protein identifiers

Doublesex- and mab-3-related transcription factor C2Q8IXT2 (reviewed: Q8IXT2)

All UniProt accessions (5): Q8IXT2, B4DX56, M0QZH7, M0R1Z9, M0R2D7

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in sexual development.

Subcellular location. Nucleus.

Tissue specificity. Expressed in testis and pancreas.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Similarity. Belongs to the DMRT family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8IXT2-11yes
Q8IXT2-22

RefSeq proteins (1): NP_001035373* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001275DM_DNA-bdDomain
IPR026607DMRTFamily
IPR031577DMRT-C1/C2_CDomain
IPR036407DM_DNA-bd_sfHomologous_superfamily

Pfam: PF00751, PF15791

UniProt features (8 total): region of interest 2, splice variant 2, sequence conflict 2, chain 1, DNA-binding region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IXT2-F160.700.20

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 61 (showing top): GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANELLE_FISSION, GOBP_NUCLEUS_ORGANIZATION, GOBP_MALE_MEIOSIS_I, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION, GOBP_SEX_DIFFERENTIATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_HETEROCHROMATIN_ORGANIZATION, AGCTCCT_MIR28, GOBP_MEIOTIC_CELL_CYCLE, GOCC_SEX_CHROMOSOME, LEIN_CEREBELLUM_MARKERS, GOCC_XY_BODY

GO Biological Process (7): male meiosis I (GO:0007141), spermatid nucleus elongation (GO:0007290), sex differentiation (GO:0007548), heterochromatin organization (GO:0070828), regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), cell differentiation (GO:0030154)

GO Molecular Function (6): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), identical protein binding (GO:0042802), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), sequence-specific DNA binding (GO:0043565)

GO Cellular Component (3): chromatin (GO:0000785), XY body (GO:0001741), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
meiosis I1
male meiotic nuclear division1
male gamete generation1
meiotic cell cycle1
nucleus organization1
spermatid nucleus differentiation1
developmental process involved in reproduction1
chromatin organization1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
cellular developmental process1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
protein binding1
cation binding1
double-stranded DNA binding1
sequence-specific DNA binding1
nucleic acid binding1
DNA binding1
chromosome1
cellular anatomical structure1
sex chromosome1
condensed chromatin of inactivated sex chromosome1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

566 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DMRTC2LYPD4Q6UWN0571
DMRTC2C10orf120Q5SQS8513
DMRTC2SOX30O94993483
DMRTC2NCAPHQ15003479
DMRTC2C5orf47Q569G3477
DMRTC2IQCF1Q8N6M8459
DMRTC2CCDC27Q2M243444
DMRTC2CCDC83Q8IWF9441
DMRTC2PKMYT1Q99640424
DMRTC2CDADC1Q9BWV3421
DMRTC2RCHY1Q96PM5398
DMRTC2ACCSLQ4AC99394
DMRTC2RBBP8NLQ8NC74393
DMRTC2SAXO1Q8IYX7386
DMRTC2DEFB112Q30KQ8384

IntAct

3 interactions, top by confidence:

ABTypeScore
IRF9DMRTC2psi-mi:“MI:0915”(physical association)0.370
TXNRD1DMRTC2psi-mi:“MI:0915”(physical association)0.370

BioGRID (3): DMRTC2 (Proximity Label-MS), DMRTC2 (Two-hybrid), TXNRD1 (Two-hybrid)

ESM2 similar proteins: A0A5F9ZHS7, A1YGK1, A2T7E6, A8MZG2, O08574, O43593, O60393, O75593, O88621, O95231, P0C1T1, P0CG20, P20428, P97609, Q04667, Q17QR5, Q2KIS6, Q2M1V0, Q2T9Q7, Q32LE6, Q497V6, Q5JUK2, Q5M844, Q5RJB0, Q5TGS1, Q61645, Q61657, Q6ZMY3, Q6ZN32, Q6ZNG2, Q7RTU1, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8N1L9, Q8N7G0, Q8N944, Q8N9Y4

Diamond homologs: A2A9A2, A2A9I7, A4QNP7, A6QQ94, A8TSS9, B0I1G7, B7ZS42, C0LZJ1, D4A218, F6W2R2, G5EEJ1, J7FCF0, O18214, P23023, P57690, P83758, P85119, Q18248, Q19291, Q2I327, Q2MJB4, Q32LE6, Q3LH63, Q4AE28, Q5UU75, Q5VZB9, Q6YHU8, Q71MM5, Q76L87, Q801F8, Q80WT2, Q8BG36, Q8CFG4, Q8CGW9, Q8IXT2, Q8JIR6, Q90WM5, Q96MA1, Q96SC8, Q9DFI0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

53 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance47
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1180 predictions. Top by Δscore:

VariantEffectΔscore
19:41847420:CCTA:Cacceptor_loss1.0000
19:41847421:CTA:Cacceptor_loss1.0000
19:41847423:A:AGacceptor_gain1.0000
19:41847423:AG:Aacceptor_loss1.0000
19:41847424:G:GAacceptor_gain1.0000
19:41847424:G:GCacceptor_loss1.0000
19:41847424:GATCC:Gacceptor_gain1.0000
19:41847649:TCCT:Tdonor_gain1.0000
19:41847651:CT:Cdonor_gain1.0000
19:41847651:CTG:Cdonor_loss1.0000
19:41847653:G:GGdonor_gain1.0000
19:41847653:GTG:Gdonor_loss1.0000
19:41847654:TGAG:Tdonor_loss1.0000
19:41848450:A:AGacceptor_gain1.0000
19:41848450:AGCT:Aacceptor_gain1.0000
19:41848451:G:GGacceptor_gain1.0000
19:41848451:GCTG:Gacceptor_gain1.0000
19:41850381:A:Tdonor_gain1.0000
19:41850384:G:GTdonor_gain1.0000
19:41850448:G:GTdonor_gain1.0000
19:41847416:T:TAacceptor_gain0.9900
19:41847424:GA:Gacceptor_gain0.9900
19:41847424:GAT:Gacceptor_gain0.9900
19:41847424:GATC:Gacceptor_gain0.9900
19:41847648:ATCCT:Adonor_gain0.9900
19:41847650:CCT:Cdonor_gain0.9900
19:41847657:G:GGdonor_gain0.9900
19:41847734:AG:Aacceptor_gain0.9900
19:41847735:GG:Gacceptor_gain0.9900
19:41847735:GGGA:Gacceptor_gain0.9900

AlphaMissense

2325 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:41847561:T:AC45S0.999
19:41847561:T:CC45R0.999
19:41847562:G:CC45S0.999
19:41847572:T:AH48Q0.999
19:41847572:T:GH48Q0.999
19:41847615:T:CF63L0.999
19:41847617:C:AF63L0.999
19:41847617:C:GF63L0.999
19:41847552:T:CC42R0.998
19:41847565:G:CR46P0.998
19:41847639:T:CC71R0.998
19:41847593:G:CK55N0.997
19:41847593:G:TK55N0.997
19:41847602:G:CK58N0.997
19:41847602:G:TK58N0.997
19:41847609:T:CC61R0.997
19:41847615:T:AF63I0.997
19:41847615:T:GF63V0.997
19:41847616:T:CF63S0.997
19:41847616:T:GF63C0.997
19:41847630:T:CC68R0.997
19:41847639:T:AC71S0.997
19:41847640:G:CC71S0.997
19:41847740:C:AR77S0.997
19:41847754:G:AM81I0.997
19:41847754:G:CM81I0.997
19:41847754:G:TM81I0.997
19:41847552:T:AC42S0.996
19:41847553:G:AC42Y0.996
19:41847553:G:CC42S0.996

dbSNP variants (sampled 300 via entrez): RS1000189887 (19:41847796 A>G), RS1000560049 (19:41845743 C>G), RS1003742123 (19:41844359 C>T), RS1004270385 (19:41850172 A>C,G), RS1004332060 (19:41844100 A>T), RS1004380739 (19:41844317 G>A,T), RS1004643641 (19:41848490 C>A,T), RS1005010048 (19:41848737 C>T), RS1005306364 (19:41851349 G>A,T), RS1005363391 (19:41844920 C>T), RS1005687063 (19:41851576 G>A,C), RS1007721871 (19:41846121 G>T), RS1008061142 (19:41852822 G>A), RS1008438100 (19:41849152 C>G,T), RS1008723125 (19:41847890 C>A,T)

Disease associations

OMIM: gene MIM:614806 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010703_14Brain morphology (MOSTest)1.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratroldecreases expression, affects cotreatment2
bisphenol Aaffects cotreatment, decreases methylation1
Temozolomideaffects response to substance1
Fulvestrantaffects cotreatment, decreases methylation1
Carmustineaffects response to substance1
Copperaffects cotreatment, decreases expression1
Plant Extractsaffects cotreatment, decreases expression1

Cellosaurus cell lines

2 cell lines: 2 embryonic stem cell

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_A1A1SEES3-1V human DMRTC2, clone1Embryonic stem cellMale
CVCL_A1A2SEES3-1V human DMRTC2, clone2Embryonic stem cellMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.